The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.
Related Posts
Upended by Meth, Some Communities Are Paying Users to Quit
Unlike with opioids, there is no medication to suppress cravings for meth and other stimulants. As use soars, hundreds of…
The Etiquette of Remembering Your Friend’s Pet’s Name
Kiyomi Lowe regularly hears people mispronounce her name or sometimes forget it altogether. “I get Naomi, Kaiomi, sometimes Kimmy,” she…
Moderate Drinking Raises Health Risks While Offering Few Benefits
A federal analysis that will shape the influential U.S. Dietary Guidelines questions alcohol’s overall benefits.